Hemagen Diagnostics, Inc. 

(Public, OTC:HMGN)   Watch this stock   
Find more results for HMGN

Key stats and ratios

Q3 (Sep '09) 2009
Net profit margin -14.72% -13.45%
Operating margin -7.51% -6.42%
EBITD margin - -3.52%
Return on average assets -20.49% -17.19%
Return on average equity - -
Employees 22 -

Address

9033 Red Branch Road
Columbia, MD 21045
United States - Map
+1-443-7403198 (Phone)
+1-443-3675527 (Fax)

Website links

Hemagen Diagnostics, Inc. discussions

  View all discussions »

Description

Hemagen Diagnostics, Inc. (Hemagen) is a biotechnology company that develops, manufactures, and markets approximately 68 United States Food and Drug Administration (FDA) cleared medical diagnostic test kits and components. The Company has two different product lines: the Virgo line and the Analyst line. The Virgo product line consist of various diagnostic test kits that are used to aid in the diagnosis of certain autoimmune and infectious diseases, using enzyme linked immunosorbent assay (ELISA), Immunoflourescence, and hemagglutination technology. The Analyst product line is an FDA-cleared Benchtop Clinical Chemistry Analyzer System, including consumables that are used to measure important constituents in human and animal blood. Hemagen also markets the Virgo product line in South America through its wholly owned subsidiary, Hemagen Diagnosticos Comercio, Importacao Exportacao, Ltd. (HDC).

Officers and directors

William P. Hales
Chairman of the Board, President, Chief Executive Officer
Age: 47
Catherine M. Davidson
Principal Accounting and Financial Officer, Controller
Age: 44
Alan S. Cohen
Director
Age: 83
Edward T. Lutz
Director
Age: 63